Digital Archives - The European Files

Rare diseases as a strategic driver of Europe’s biotech leadership

By Avril Daly

For decades, Europe has been losing ground in the global competition for life sciences investment, research, and development. The Biotech

By Nathalie Moll

Europe has enormous strengths in science, manufacturing and its industrial base, but struggles to translate this into investment, clinical trials

By Isabelle Deschamps

Europe has the makings of a biopharmaceutical superpower and behaves as if it did not. The science is here, the

By Dr Alexander Natz / Stefano Romanelli

The role of the European Union (EU) in defining healthcare policy has become more prominent after the outbreak of the

By Olivér Várhelyi

Europe’s healthcare systems are among our greatest achievements. They are built on a simple promise: that people should receive the

By Frank Vandenbroucke

With a provisional agreement on the Critical Medicines Act reached on 12 May 20261, Europe has taken a step forward

By Jorgo Chatzimarkakis

With the dramatic increase in the use of artificial intelligence (AI) tools only set to accelerate, an associated increase in

By Yvan Verougstraete

In 2026, the general consensus is that Europe is losing its edge and, at this rate, will fall entirely behind